Junji Lin, PhD

Associate Director, Global Value & HEOR
Jazz Pharmaceuticals, Philadelphia, PA, USA

Poster(s):

• (307) Epidemiology and diagnostic landscape for gastroesophageal adenocarcinomas with a HER2 focus
  Wednesday, October 29, 2025

• (329) A systematic review of economic evidence of advanced or metastatic gastroesophageal adenocarcinoma
  Wednesday, October 29, 2025